VRTX - Financial Reports List - Vertex Pharmaceuticals Incorporated - IntrinsicAlpha

Vertex Pharmaceuticals Incorporated VRTX

Healthcare - Biotechnology - NASDAQ - US

$ 490.47

-2.37 %

$ 126 B

Market Cap

-227.39

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	15.66%	-5.76%	7.01%
Annual Report	FY	10-K	2024-12-31	11.66%	-14.80%	-5.41%
Quarterly Report	Q3	8-K	2024-09-30	11.61%	0.98%	7.53%
Quarterly Report	Q2	8-K	2024-06-30	5.68%	-392.44%	-343.44%
Quarterly Report	Q1	8-K	2024-03-31	13.15%	57.13%	45.83%
Quarterly Report	Q4	8-K	2023-12-31	9.34%	18.31%	-7.23%
Annual Report	FY	10-K	2023-12-31	10.51%	8.96%	0.00%
Quarterly Report	Q3	8-K	2023-09-30	6.39%	11.26%	-7.86%
Quarterly Report	Q2	8-K	2023-06-30	13.52%	12.98%	-7.22%
Quarterly Report	Q1	8-K	2023-03-31	13.22%	-8.17%	-25.16%

1